Raymond James & Associates’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $49.6K | Sell |
15,752
-2,003
| -11% | -$6.31K | ﹤0.01% | 3808 |
|
|
2024
Q2 | $39.2K | Hold |
17,755
| – | – | ﹤0.01% | 3776 |
|
|
2024
Q1 | $55.4K | Sell |
17,755
-37,894
| -68% | -$118K | ﹤0.01% | 3755 |
|
|
2023
Q4 | $216K | Sell |
55,649
-933
| -2% | -$3.62K | ﹤0.01% | 3449 |
|
|
2023
Q3 | $185K | Buy |
56,582
+100
| +0.2% | +$327 | ﹤0.01% | 3459 |
|
|
2023
Q2 | $181K | Sell |
56,482
-467
| -0.8% | -$1.49K | ﹤0.01% | 3469 |
|
|
2023
Q1 | $245K | Sell |
56,949
-268
| -0.5% | -$1.15K | ﹤0.01% | 3350 |
|
|
2022
Q4 | $243K | Sell |
57,217
-3,629
| -6% | -$15.4K | ﹤0.01% | 3315 |
|
|
2022
Q3 | $299K | Sell |
60,846
-4,672
| -7% | -$23K | ﹤0.01% | 3164 |
|
|
2022
Q2 | $200K | Sell |
65,518
-50
| -0.1% | -$153 | ﹤0.01% | 3480 |
|
|
2022
Q1 | $180K | Buy |
65,568
+8,666
| +15% | +$23.8K | ﹤0.01% | 3660 |
|
|
2021
Q4 | $169K | Buy |
56,902
+5,352
| +10% | +$15.9K | ﹤0.01% | 3718 |
|
|
2021
Q3 | $246K | Sell |
51,550
-2,506
| -5% | -$12K | ﹤0.01% | 3529 |
|
|
2021
Q2 | $210K | Buy |
54,056
+11,726
| +28% | +$45.6K | ﹤0.01% | 3626 |
|
|
2021
Q1 | $198K | Buy |
+42,330
| New | +$198K | ﹤0.01% | 3574 |
|
|
2020
Q2 | – | Sell |
-10,040
| Closed | -$16K | – | 3396 |
|
|
2020
Q1 | $16K | Hold |
10,040
| – | – | ﹤0.01% | 3353 |
|
|
2019
Q4 | $33K | Hold |
10,040
| – | – | ﹤0.01% | 3508 |
|
|
2019
Q3 | $40K | Hold |
10,040
| – | – | ﹤0.01% | 3437 |
|
|
2019
Q2 | $36K | Buy |
+10,040
| New | +$36K | ﹤0.01% | 3458 |
|